RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 605.00
-18.00 (-2.89%)
Oct 26, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 15.75 billion as of October 26, 2026. It is the 25,089th most valuable company in the world and the 2,136th biggest in Japan. Its market cap has increased by 20.59% in one year.
Market Cap
15.75B
Enterprise Value
13.74B
Revenue
3.90B
Global Rank
Country Rank
#2,136 Japan
PE Ratio
95.65
ChartMarket Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 15.75B, a decrease of -20.86%. That is a compound annual growth rate of -1.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 15.75B | -36.24% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 29.73B |
| Innovacell | 21.13B |
| Stella Pharma | 14.67B |
| CanBas | 14.07B |
| ReproCELL | 12.67B |
| AnGes | 11.57B |
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |